early phase
Dr. Akhilesh Sharma, Senior VP, Dr. Reddy's Laboratories on Target Engagement, Translational Strategies and Timelines in Early Phase Clinical Trials
May 14 by Andrea CharlesDr. Akhilesh Sharma, Senior Vice President and Global Head of Global Medical Affairs at Dr. Reddy's Laboratories, joins Andrea Charles from Pharma IQ, to discuss emerging trends in ear...
Leading Regulatory Bodies, Pharmaceutical and Biotech Companies Including MHRA, FAGGS and BfArM to Address the Challenges Facing Today's Phase I Trials
July 06 by Pharma IQ NewsLONDON- Pharma IQ is pleased to announce the dates for the Innovation in Phase I Clinical Development conference taking place on 21st and 22nd September 2010. With the focus on cost control more...
Fail Early in Clinical Development if You Want to Succeed
June 10 by Andrea CharlesIf you are going to fail, it is better to fail earlier. All phases of clinical research are striving to reduce attrition, streamline their processes and develop drugs cost-effectively.
Huichen Liu, Clinical Pharmacology, Aerospace Center Hospital: 60 Second Interview
March 28 by Huichen LiuWith increasing emphasis on implementing effective early phase trial strategies in Asia, companies are looking to reduce approval timlines, risks and costs from first-in human through proof of...
The Failure Rate at Phase Three is Probably 70% or Greater
March 28 by Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH,Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH, Senior Medical Director, PharmaNet Development Group, Inc, join Pharma IQ to discuss adaptive trial design. Pharma...